company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 15:32:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3055000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 15:32:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3055000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 15:32:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2849000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 15:32:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2849000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 15:32:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,206000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 15:32:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1238000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 15:32:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4596000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 15:32:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5834000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 15:32:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5628000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 15:32:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,887000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 15:32:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,38000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 15:32:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-336000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 15:32:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1185000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 15:32:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6813000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 15:32:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6813000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 15:32:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6813000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 15:32:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6813000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 15:32:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,600000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 15:32:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-11.86
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 15:32:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,600000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 15:32:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-11.86
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 15:32:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,574496.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q2,2010-04-01,2010-06-30,2011-08-11 15:32:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-11.86
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 15:17:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4532000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 15:17:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4532000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 15:17:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3573000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 15:17:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3573000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 15:17:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,959000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 15:17:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1694000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 15:17:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5716000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 15:17:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7410000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 15:17:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6451000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 15:17:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1077000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 15:17:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,39000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 15:17:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-411000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 15:17:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1449000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 15:17:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7900000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 15:17:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7900000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 15:17:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7900000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 15:17:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7900000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 15:17:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,573521.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 15:17:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-13.77
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 15:17:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,573521.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 15:17:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-13.77
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 15:17:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,600000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 15:17:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-13.77
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3863000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3863000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3667000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3667000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,196000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3523000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3795000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7318000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7122000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2481000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,29000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-201000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2653000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9775000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9775000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9775000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9775000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,10014042.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.98
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,10014042.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.98
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,10000000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 12:00:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.98
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,2011-08-11 15:32:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3636000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,2011-08-11 15:32:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3636000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,2011-08-11 15:32:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3115000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,2011-08-11 15:32:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3115000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,2011-08-11 15:32:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,521000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,2011-08-11 15:32:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4671000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,2011-08-11 15:32:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4381000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,2011-08-11 15:32:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9052000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,2011-08-11 15:32:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8531000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,2011-08-11 15:32:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,676000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,2011-08-11 15:32:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,37000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,2011-08-11 15:32:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,407000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,2011-08-11 15:32:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-232000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,2011-08-11 15:32:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8763000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,2011-08-11 15:32:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8763000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,2011-08-11 15:32:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8763000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,2011-08-11 15:32:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8763000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,2011-08-11 15:32:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17200000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,2011-08-11 15:32:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.51
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,2011-08-11 15:32:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17200000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,2011-08-11 15:32:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.51
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,2011-08-11 15:32:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17233146.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q2,2011-04-01,2011-06-30,2011-08-11 15:32:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.51
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,2011-10-31 15:17:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3956000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,2011-10-31 15:17:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3956000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,2011-10-31 15:17:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3357000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,2011-10-31 15:17:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3357000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,2011-10-31 15:17:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,599000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,2011-10-31 15:17:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4988000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,2011-10-31 15:17:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4344000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,2011-10-31 15:17:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9332000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,2011-10-31 15:17:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8733000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,2011-10-31 15:17:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,910000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,2011-10-31 15:17:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,46000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,2011-10-31 15:17:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,89000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,2011-10-31 15:17:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-775000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,2011-10-31 15:17:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9508000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,2011-10-31 15:17:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9508000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,2011-10-31 15:17:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9508000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,2011-10-31 15:17:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9508000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,2011-10-31 15:17:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17230826.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,2011-10-31 15:17:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.55
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,2011-10-31 15:17:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17230826.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,2011-10-31 15:17:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.55
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,2011-10-31 15:17:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17300000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q3,2011-07-01,2011-09-30,2011-10-31 15:17:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.55
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4234000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4234000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6600000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6600000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-2366000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6977000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2353000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,3019000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12349000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14715000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,713000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,143000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-567000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15282000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15282000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15282000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15282000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16437000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.6
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16437000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.6
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16437464.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.6
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7804000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7804000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6495000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6495000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1309000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11152000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1294000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12446000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11137000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,514000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,63000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-306000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-757000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11894000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11894000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11894000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11894000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25367306.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.47
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25367306.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.47
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25300000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 12:00:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.47
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12344000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12344000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6685000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6685000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5659000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10413000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1872000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12285000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6626000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,494000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,68000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-182000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-608000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7234000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7234000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-1062000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8296000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8296000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30954000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30954000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30953635.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 11:09:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,2012-11-01 14:49:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8486000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,2012-11-01 14:49:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8486000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,2012-11-01 14:49:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9287000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,2012-11-01 14:49:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9287000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,2012-11-01 14:49:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-801000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,2012-11-01 14:49:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11378000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,2012-11-01 14:49:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3527000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,2012-11-01 14:49:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14905000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,2012-11-01 14:49:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15706000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,2012-11-01 14:49:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,456000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,2012-11-01 14:49:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,87000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,2012-11-01 14:49:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,330000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,2012-11-01 14:49:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-39000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,2012-11-01 14:49:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15745000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,2012-11-01 14:49:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15745000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,2012-11-01 14:49:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15745000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,2012-11-01 14:49:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15745000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,2012-11-01 14:49:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32436000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,2012-11-01 14:49:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,2012-11-01 14:49:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32436000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,2012-11-01 14:49:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.49
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,2012-11-01 14:49:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32436207.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q3,2012-07-01,2012-09-30,2012-11-01 14:49:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10450000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10450000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9672000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9672000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,778000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13363000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3244000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16607000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15829000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1405000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,57000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-231000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1579000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17408000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17408000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,1062000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16346000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16346000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30332000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30332000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.49
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30332000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11587000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11587000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11391000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11391000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,196000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12936000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5905000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18841000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18645000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1519000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,73000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3489000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4935000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23580000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23580000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,442000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23138000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23138000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32709000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.71
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32709000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.71
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32709298.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q1,2013-01-01,2013-03-31,2013-05-08 12:03:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.71
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 12:44:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17141000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 12:44:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17141000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 12:44:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10214000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 12:44:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10214000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 12:44:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6927000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 12:44:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14080000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 12:44:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4857000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 12:44:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18937000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 12:44:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12010000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 12:44:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1914000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 12:44:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,72000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 12:44:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-179000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 12:44:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2021000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 12:44:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14031000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 12:44:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14031000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 12:44:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14031000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 12:44:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14031000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 12:44:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33083000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 12:44:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.42
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 12:44:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33083000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 12:44:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.42
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 12:44:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33083289.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 12:44:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.42
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23259000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23259000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14791000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14791000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8468000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15320000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5962000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21282000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12814000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1892000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,62000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-140000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1970000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14784000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14784000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14784000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14784000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33360000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.44
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33360000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.44
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33359576.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q3,2013-07-01,2013-09-30,2013-10-31 14:03:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.44
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33564000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33564000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18376000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18376000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15188000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20172000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4836000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25008000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9820000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5326000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,52000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3138000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2136000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11956000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-442000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11514000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-442000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11956000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11956000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33182000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33182000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33182000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,36662000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,36662000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18127000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18127000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18535000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,22589000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5204000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27793000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9258000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2107000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,42000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-154000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2219000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11477000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11477000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11477000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11477000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33711000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33711000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33710970.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q1,2014-01-01,2014-03-31,2014-05-01 13:51:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,47165000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,47165000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,19954000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,19954000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27211000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24837000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5216000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30053000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2842000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2079000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,61000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-177000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2195000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5037000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5037000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5037000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5037000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35463000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35463000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36000000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q2,2014-04-01,2014-06-30,2015-07-30 16:32:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,52048000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,52048000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20391000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20391000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31657000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,28217000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4425000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32642000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-985000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2037000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,134000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-116000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2019000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3004000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3004000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3004000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3004000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35943000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35943000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37600000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 15:03:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,61793000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,61793000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18968000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18968000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,42825000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,31019000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3886000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34905000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7920000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2055000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,145000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-35000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1945000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5975000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,173000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5802000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5802000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5802000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35299000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.17
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35299000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.17
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35200000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.17
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,58316000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,58316000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17580000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17580000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40736000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,31428000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5967000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37395000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3341000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1996000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,155000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-188000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2029000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1312000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,52000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1260000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1260000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1260000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36235000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.03
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41779000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.03
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42000000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 14:13:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.03
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:10:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,59148000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:10:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,59148000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:10:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18929000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:10:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18929000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:10:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40219000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:10:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,34752000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:10:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3649000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:10:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38401000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:10:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1818000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:10:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1991000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:10:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,177000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:10:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,43000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:10:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1771000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:10:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,47000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:10:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,39000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:10:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:10:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:10:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:10:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36481000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:10:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:10:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41445000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:10:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:10:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,62213000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,62213000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,15901000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,15901000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,46312000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,35310000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5893000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41203000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5109000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1905000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,171000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-8000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1742000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3367000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,281000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3086000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3086000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3086000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36663000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41043000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38600000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 15:02:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,69320000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,69320000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,19427000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,19427000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,49893000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,37553000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13153000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,50706000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-813000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1885000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,175000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-83000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1793000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2606000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-108000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2498000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2498000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2498000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36540000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41301000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37100000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,65474000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,65474000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20278000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20278000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,45196000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,37957000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9493000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47450000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2254000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1868000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,252000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,48000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1568000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3822000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,32000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3854000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3854000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3854000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37020000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37020000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37020000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 14:40:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,69640000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,69640000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,23053000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,23053000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,46587000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,43669000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9362000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,53031000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6444000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1733000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,324000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-47000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1456000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7900000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,58000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7958000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7958000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7958000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37181000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37181000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37181000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 15:10:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,68355000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,68355000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,43152000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,43152000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25203000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,36314000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9754000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,46068000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20865000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1601000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,346000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-8000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1263000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22128000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,36000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22164000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22164000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22164000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37312000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.59
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37312000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.59
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37312000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:11:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.59
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,72902000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,72902000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,23621000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,23621000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,49281000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,34673000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17069000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,51742000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2461000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1859000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,401000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-75000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1533000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3994000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-21000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3973000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3973000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3973000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37236000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37236000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37236000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,69283000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,69283000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,24581000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,24581000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,44702000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,42120000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16632000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,58752000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14050000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6310000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,514000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5786000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19836000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,30000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19866000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19866000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19866000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37998000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.52
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37998000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.52
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37998000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 15:20:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.52
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,70934000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,70934000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,23811000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,23811000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,47123000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,39552000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18856000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4495000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62903000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15780000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5237000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1224000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,80000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3933000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19713000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,30000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19743000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19743000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19743000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40160000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40160000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.49
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40300000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 15:39:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,67335000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,67335000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18228000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18228000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,49107000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,40644000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11775000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,260000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52679000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3572000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5127000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1068000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,79000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3980000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7552000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,45000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7597000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7597000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7597000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40463000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40000000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40000000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 12:16:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,79078000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,79078000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,21295000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,21295000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,57783000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,39178000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10027000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-4755000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4868000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,49318000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8465000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5105000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1272000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3835000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4630000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,35000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4595000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4595000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4595000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39800000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,39806000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.13
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39806000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.13
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,74607000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,74607000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,22885000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,22885000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,51722000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44191000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14378000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,90000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,58659000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6937000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5157000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1374000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,75000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3708000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10645000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,35000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10680000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10680000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10680000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40707000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41100000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41100000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 15:43:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,83448000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,83448000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,19065000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,19065000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,64383000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44179000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14897000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1259000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60335000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4048000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5642000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1586000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-694000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4750000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-702000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-62000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-640000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-640000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-640000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32000000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32000000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40995000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 18:12:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,176222000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,176222000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,23979000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,23979000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,152243000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44646000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14174000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,79596000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1564000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,139980000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12263000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5753000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2004000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-191000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3940000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8323000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,38000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8285000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8285000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8285000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47100000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47100000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40911000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,91313000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,91313000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,27303000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,27303000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,64010000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,47305000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14384000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1242000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62931000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1079000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5814000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2156000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,61000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3597000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2518000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,253000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2771000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2771000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2771000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41240000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41240000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39600000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 15:48:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,102604000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,102604000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,25201000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,25201000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,77403000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,49126000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17827000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1770000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3405000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,72128000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5275000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5878000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1817000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-87000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4148000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1127000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1603000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2730000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2730000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2730000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41384000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.07
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42345000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.06
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39000000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 14:32:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.07
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,104685000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,104685000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,22304000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,22304000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,82381000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,50128000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20255000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1967000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,7618000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,79968000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2413000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5940000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1736000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4025000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8229000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5816000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,300000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6116000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6087000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6087000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40600000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40600000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41645000.0
Pacira Pharmaceuticals Inc,PCRX,549300P56LERYBDHCF69,0001396814,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 18:12:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
